SCHEMBL7176512

SCHEMBL7176512

O=C(CNC(=O)OCc1ccccc1)Oc1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.62
LMNA P02545 2/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
HTT P42858 2/20 0.54
ALDH1A1 P00352 4/20 0.52
CTSL P07711 1/20 0.51
CTSB P07858 1/20 0.51
CTSS P25774 1/20 0.51
CTSK P43235 1/20 0.51
MAPT P10636 2/20 0.51
GAA P10253 1/20 0.51
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
TPSAB1 Q15661 1/20 0.50
TPSD1 Q9BZJ3 1/20 0.50
TPSG1 Q9NRR2 1/20 0.50
L3MBTL1 Q9Y468 2/20 0.49
MAPK1 P28482 1/20 0.49
KDM4E B2RXH2 1/20 0.48
MEN1 O00255 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10915714 0.93 ATM (0.62) ATMLMNASMN1; SMN2HTTALDH1A1
SCHEMBL7758173 0.90 ATM (0.60) ATMLMNASMN1; SMN2HTTALDH1A1
SCHEMBL11027505 0.89 ATM (0.56) ATMLMNASMN1; SMN2HTTALDH1A1
SCHEMBL10081124 0.87 LMNA (0.63) ATMLMNASMN1; SMN2HTTALDH1A1
SCHEMBL11589991 0.87 MAPT (0.57) ATMLMNASMN1; SMN2ALDH1A1MAPT
SCHEMBL11511321 0.86 ATM (0.71) ATMLMNASMN1; SMN2HTTALDH1A1
SCHEMBL7759657 0.86 ATM (0.55) ATMLMNASMN1; SMN2HTTALDH1A1
SCHEMBL1803004 0.86 ATM (0.55) ATMHTTALDH1A1MAPTGAA
SCHEMBL10641387 0.85 LMNA (0.61) ATMLMNASMN1; SMN2HTTALDH1A1
SCHEMBL7758148 0.85 ATM (0.54) ATMLMNASMN1; SMN2HTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-3963728-A ACYLATION OF NITROGEN CONTAINING COMPOUNDS USING ESTERS KYOWA HAKKO KOGYO CO., LTD. (JA) 1976-06-15 US claimed
US-6569847-B1 Inhibitors of cathepsins for treating muscular dystrophy, osteoporosis, rheumatoid arthritis, neuronal or cardiac ischaemia, allergy, or Chagas disease NAEJA PHARMACEUTICALS INC. (CA) 2003-05-27 US disclosed
US-6509506-B1 Asymmetric aminohydroxylation of olefins using osmium catalyst; oxidation THE SCRIPPS RESEARCH INSTITUTE 2003-01-21 US disclosed
EP-1165506-A1 SUBSTITUTED AZETIDIN-2-ONES AS CYSTEINE PROTEASE INHIBITORS Naeja Pharmaceutical Inc. (CA) 2002-01-02 EP disclosed
WO-2000059881-A1 SUBSTITUTED AZETIDIN-2-ONES AS CYSTEINE PROTEASE INHIBITORS NAEJA PHARMACEUTICAL INC (CA) 2000-10-12 WO disclosed
US-4172199-A ISOOXACEPHALOSPORINS BRISTOL-MYERS COMPANY (US) 1979-10-23 US disclosed
US-4113946-A Δ2,3 -1,4-Morpholine-2-carboxylic acid derivatives as antibacterial agents BRISTOL-MYERS COMPANY (US) 1978-09-12 US disclosed
US-4066831-A ANTIBIOTICS BRISTOL-MYERS COMPANY (US) 1978-01-03 US disclosed
US-4065623-A O-2-Isocephem-4-carboxylic acid derivatives as antibacterial agents BRISTOL-MYERS COMPANY (US) 1977-12-27 US disclosed
US-RE29369-E AMIDE PRODUCT, SALTS OF HYDROXY-SUBSTITUTED PYRIDINE COMPOUNDS KYOWA HAKKO KOGYO CO., LTD. (JA) 1977-08-23 US disclosed
US-4043992-A Method for preparing acylated products KYOWA HAKKO KOGYO CO., LTD. (JA) 1977-08-23 US disclosed
US-4012383-A BACTERICIDES BRISTOL-MYERS COMPANY (US) 1977-03-15 US disclosed
US-3963728-A ACYLATION OF NITROGEN CONTAINING COMPOUNDS USING ESTERS KYOWA HAKKO KOGYO CO., LTD. (JA) 1976-06-15 US disclosed